Divis Laboratories

Market Cap (₹ Cr.)

₹1,56,524

52 Week High

6,275.85

Book Value

₹511

52 Week Low

3,350.00

PE Ratio

85.25

PB Ratio

11.41

PE for Sector

37.14

PB for Sector

4.89

ROE

11.79 %

ROCE

15.26 %

Dividend Yield

0.51 %

EPS

₹63.06

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

0.89 %

Net Income Growth

-12.28 %

Cash Flow Change

-48.72 %

ROE

-17.48 %

ROCE

-19.14 %

EBITDA Margin (Avg.)

-7.05 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	830	843	994	874	1,121	1,034	1,026	998	1,088	851	924	1,055	1,136	1,044	1,365	1,377	1,298	1,172	1,451	1,431	1,453	1,728	1,727	1,676	1,741	1,986	1,987	2,483	2,546	2,294	1,902	1,807	1,974	1,810	1,953	1,902	2,338	2,142	2,407
Expenses	502	507	588	536	704	613	714	599	705	576	613	712	701	643	771	820	845	761	919	894	928	1,011	981	978	1,019	1,099	1,149	1,367	1,399	1,367	1,214	1,281	1,419	1,239	1,394	1,317	1,542	1,442	1,573
EBITDA	328	336	406	338	417	420	311	399	383	275	311	343	435	401	594	558	453	410	533	537	525	717	746	698	722	887	838	1,117	1,146	927	688	526	555	571	559	585	796	700	834
Operating Profit %	38 %	37 %	39 %	38 %	36 %	40 %	29 %	39 %	34 %	30 %	31 %	31 %	36 %	35 %	40 %	39 %	33 %	33 %	35 %	36 %	33 %	41 %	43 %	41 %	41 %	44 %	42 %	45 %	44 %	38 %	33 %	24 %	26 %	28 %	25 %	27 %	32 %	30 %	32 %
Depreciation	45	29	30	30	29	30	31	31	31	32	34	37	39	42	42	42	42	44	46	47	50	56	61	68	70	73	77	80	81	83	85	87	87	93	94	95	94	97	98
Interest	1	0	0	0	2	0	0	0	1	0	1	0	-0	1	0	3	0	0	4	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	2	0	1
Profit Before Tax	283	307	376	308	385	390	280	368	350	242	276	306	396	358	552	513	410	366	483	489	475	661	685	630	652	814	760	1,037	1,066	844	603	439	468	478	464	490	700	603	735
Tax	54	62	79	61	95	81	58	75	48	48	55	61	123	86	148	130	109	94	120	122	53	186	144	143	135	239	134	119	145	138	90	105	105	123	108	121	159	178	218
Net Profit	229	245	297	247	322	302	224	268	259	177	207	225	262	266	398	379	289	267	353	361	392	492	513	461	488	552	606	907	883	691	487	310	319	345	342	358	531	430	518
EPS in ₹	17.25	18.32	11.14	9.30	12.14	11.37	8.43	10.11	9.77	6.65	7.79	8.46	9.85	10.03	14.98	14.29	10.90	10.07	13.29	13.59	14.76	18.54	19.34	17.37	18.38	20.79	22.84	34.17	33.26	26.05	18.34	11.71	12.01	12.99	12.89	13.50	19.99	16.18	19.51

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	4,475	4,965	6,210	6,808	8,040	8,514	10,724	13,308	14,352	15,362
Fixed Assets	1,309	1,439	1,559	1,996	2,087	2,776	3,699	4,321	4,719	4,737
Current Assets	2,796	3,058	4,039	4,554	4,647	4,661	6,125	8,296	9,236	9,572
Capital Work in Progress	218	264	444	120	492	920	711	470	212	778
Investments	733	813	1,639	1,897	1,953	979	7	79	84	89
Other Assets	2,215	2,450	2,568	2,795	3,508	3,839	6,307	8,438	9,337	9,758
Total Liabilities	913	608	801	848	1,067	1,197	1,452	1,617	1,647	1,878
Current Liabilities	772	516	656	640	833	903	1,089	1,168	1,079	1,259
Non Current Liabilities	140	92	145	208	234	294	363	448	568	619
Total Equity	3,562	4,357	5,409	5,960	6,973	7,317	9,272	11,691	12,705	13,484
Reserve & Surplus	3,535	4,304	5,356	5,907	6,920	7,264	9,218	11,638	12,652	13,431
Share Capital	27	53	53	53	53	53	53	53	53	53

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-1	-5	15	-25	34	36	1,988	-817	-1,056	200
Investing Activities	-521	-411	-1,137	-476	-684	-81	75	-2,195	-2,707	-268
Operating Activities	822	1,036	1,149	765	964	1,208	1,947	1,910	2,447	1,266
Financing Activities	-303	-630	3	-314	-246	-1,091	-34	-532	-796	-798

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	51.95 %	51.95 %	51.95 %	51.95 %	51.94 %	51.94 %	51.94 %	51.94 %	51.94 %	51.93 %	51.93 %	51.92 %	51.92 %	51.90 %	51.89 %
FIIs	19.87 %	20.60 %	20.70 %	19.30 %	18.45 %	16.52 %	15.40 %	15.14 %	14.67 %	14.70 %	14.60 %	14.86 %	14.68 %	16.16 %	17.25 %
DIIs	16.74 %	16.56 %	16.36 %	17.73 %	18.32 %	19.98 %	20.78 %	20.68 %	21.08 %	21.23 %	21.75 %	21.88 %	22.21 %	21.77 %	21.06 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	11.45 %	10.89 %	11.00 %	11.02 %	11.28 %	11.56 %	11.88 %	12.24 %	12.31 %	12.14 %	11.72 %	11.33 %	11.19 %	10.18 %	9.80 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,787.70	4,25,929.94	38.00	49,887.17	12.06	9,648	27.35	40.28
Divis Laboratories	5,977.10	1,56,524.27	85.25	8,184.00	0.89	1,600	46.55	56.39
Cipla	1,473.25	1,18,825.56	25.74	26,520.66	14.17	4,155	12.95	38.47
Mankind Pharma	2,531.30	1,02,885.42	48.65	10,615.63	19.57	1,942	28.89	46.80
Dr Reddys Laboratories	1,201.90	1,01,290.13	18.97	28,905.40	12.36	5,578	-9.47	32.64
Zydus Life Science	945.00	95,280.30	22.27	19,831.50	13.82	3,831	14.57	32.02
Lupin	2,038.05	92,929.19	35.38	20,141.50	19.94	1,936	73.52	37.01
Aurobindo Pharma	1,232.70	73,119.28	20.05	29,559.25	17.55	3,169	8.65	20.74
Alkem Laboratories	5,627.60	66,062.65	30.38	12,978.42	9.84	1,811	14.16	35.74
Glenmark Pharmaceuticals	1,473.85	42,112.35	-	12,653.09	6.58	-1,831	675.84	30.08